Effects of a combined exercise therapy on physical condition, muscle strength, quality of life and serum profiles in type 2 diabetes mellitus

ISRCTN ISRCTN93104189
DOI https://doi.org/10.1186/ISRCTN93104189
Secondary identifying numbers N/A
Submission date
11/03/2010
Registration date
29/04/2010
Last edited
29/04/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Armando Raimundo
Scientific

S/ Reguentos de Monsaraz, 44
Pavilhão Gimnosdesportivo
University of Évora
Évora
7005-399
Portugal

Study information

Study designSingle centre interventional randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet
Scientific titleA randomised controlled trial investigating the effects of 12 weeks of combined aerobic and resistance exercise program on serum profiles, functional capacity, isokinetic muscle strength and quality of life type 2 diabetes mellitus
Study objectivesType 2 diabetes is associated with obesity and physical inactivity and this impairment prevalence is increasing in occidental countries due to the growing predominance of obesity and sedentary life styles. The aim of this study is to analyse the adaptations induced by combined exercise on serum profiles, muscle strength and fatigue, physical fitness, corporal composition and quality of life related with health on type 2 diabetes mellitus patients.

Hypotheses:
1. The combined exercise therapy may lead to improvements in the neuromuscular function, physical fitness, metabolic parameters and health related-quality of life of type 2 diabetes patients.
2. Gains in neuromuscular function are related to improvements in metabolic parameters in patients with type 2 diabetes.
3. Gains in physical fitness are related to changes in health related-quality of life of type 2 diabetes patients.
Ethics approval(s)Ethics committee of health and well being of the University of Évora approved on the 10th of June of 2008 (ref: 08050)
Health condition(s) or problem(s) studiedType II diabetes mellitus
InterventionThe supervised exercise therapy consisted of 1 hour-session for 3-times/week and for 12-weeks. Each session included
1. 10 minutes of warming up with slow walks and easy movements of progressive intensity
2. 25 minutes of aerobic exercises at 60–65% of maximal heart rate
3. 15 minutes of strength exercises with lower and upper limb using patient's own weight resistance, light
loads (e.g. 2-4 sets of 10 repetitions of unilateral knee flexion-extension at a slow pace with the body in a vertical position or of raising the arms over the head holding a stick)
4. 10 minutes of overall mobility and cooling down.
Patients’ heart rate was monitored using a pulse-meter.
During this 3-month period, participants in the control group (CG) continued their daily activities, with no physical exercise similar to those in the therapy. There was no follow-up beyond the end of the 3 month intervention period.
Intervention typeOther
Primary outcome measureThe primary endpoint with respect to efficacy of the combined exercise therapy in type-2 diabetes patient was to produce a moderate decrease in serum glycated hemoglobine (HbA1c) levels. Therefore, this parameter was measured from fasting blood samples along others, such as fasting glucose, HDL and LDL cholesterol, triglycerides, alanino aminotransferase (ALT) and aspartate aminotrasnferase (AST) in a standardized manner at laboratories of the hospital of the city of Évora (Portugal).

Measurements were made at baseline and post-intervention at 12 weeks.
Secondary outcome measures1. Muscle condition: maximal peak force of the knee extensors and flexors was recorded by using the Biodex System-3 Isokinetic Dynamometer (Biodex Corp., Shirley, NY, USA). Each subset performed biolateral tests of maximal isokinetic leg strength and leg muscle fatigue.
2. Health-related quality of life (HRQOL), measured using the Portuguese language version of the Short Form 36 Health Survey (SF-36)
3. Body composition: percentage fat, total and abdominal, were assessed using dual-energy X-ray absorptiometry (DXA, Norland Excell Plus, Norland Inc, Fort Atkinson, USA)
4. Functional capacity of the patients, assessed by several tests, performed in a standardized manner:
4.1. Maximal walking speed test over 10 metres
4.2. 10-stairs climbing test
4.3. 10-stairs climbing test carrying a bag weighing 5 kg in each hand
4.4. Timed up and go test
4.5. 30 seconds chair stand test
4.6. 6-minutes walking test
Measurements were made at baseline and post-intervention at 12 weeks.
Overall study start date10/09/2008
Completion date21/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants50 potentially eligible, 43 gave consent (exercise group: 22; control group 21)
Key inclusion criteria1. Non-smokers and not consumers of alcohol
2. Either sex
3. Age between 30 and 70 years
4. At least 3 years with diagnosed type-2 diabetes mellitus
Key exclusion criteriaPresence of any disorders that might prevent physical training load and require other psychological, physical or nutritional therapy
Date of first enrolment10/09/2008
Date of final enrolment21/12/2008

Locations

Countries of recruitment

  • Portugal

Study participating centre

S/ Reguentos de Monsaraz, 44
Évora
7005-399
Portugal

Sponsor information

University of Évora (Portugal)
University/education

Reguengos de Monsaraz, 44
Pavilhão Gimnodesportivo
University of Évora
Évora
7005-399
Portugal

ROR logo "ROR" https://ror.org/02gyps716

Funders

Funder type

University/education

University of Évora (Portugal)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan